Yaguang Xi

miRAssist integrates six evidence types to prioritize miRNA-target interactions, outperforming existing models and providing interpretable results.

This study shows sulindac sulfide inhibits cell transformation by upregulating let-7b, which suppresses K-Ras signaling through ERK inhibition, revealing a novel regulatory axis in cancer chemoprevention.

This study shows that sulindac enhances anti-PD-L1 immunotherapy efficacy in TNBC by reducing exosomal PD-L1 and increasing T cell infiltration.